Q1 2019 Highlights
- Advanced product R&D, formulation and manufacturing at Dosecann in preparation for the legalization of derivative cannabis products:
- Progress has been made in several areas including extraction of flower to cannabis resin and development of edible product formulations, with a full product suite to be completed during the third quarter of 2019
- Successful production of oil in a bottle for sale in the second quarter of 2019
- Completed first sales of dried cannabis flower
- Advanced the process for receipt of Kolab’s oil sales approval
- Continued to work with joint venture partner Sunens as it completes phase one of a state-of-the-art greenhouse facility in 2019, with construction anticipated to be fully completed by December 2019
- Receipt of Robinsons cultivation and processing licence in Nova Scotia; progress made towards Robinsons flower sales approval by the third quarter of 2019
- Advanced construction of Kolab’s Lloydminster store, with anticipated opening date in early Q3 2019
- Inverell awarded a licence for scientific research and development of novel non-psychoactive cannabis strains for registration
- KGK applied for a research and development licence under the Cannabis Act, which is under final review by Health Canada
- Made progress toward the development of a clinical study plan at KGK to support the safety, efficacy and quality of Dosecann products
Read More